The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 123K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilkinson, R. J.
Right arrow Articles by Toossi, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilkinson, R. J.
Right arrow Articles by Toossi, Z.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1999/6/1863/ $5.00
The Journal of Experimental Medicine, Volume 189, Number 12, June 21, 1999 1863-1874


Articles

Influence of Polymorphism in the Genes for the Interleukin (IL)-1 Receptor Antagonist and IL-1β on Tuberculosis

Robert J. Wilkinson*,{ddagger}, Punita Patel{ddagger}, Martin Llewelyn{ddagger}, Christina S. Hirsch*, Geoffrey Pasvol{ddagger}, Georges Snounou{ddagger}, Robert N. Davidson{ddagger}, and Zahra Toossi*

From the * Division of Infectious Diseases, Case Western Reserve University, Cleveland, Ohio 44106-4984; and the {ddagger} Wellcome Center for Clinical Tropical Medicine, Imperial College School of Medicine, Northwick Park Hospital, Harrow HA1 3UJ, United Kingdom

Several lines of evidence suggest that host genetic factors controlling the immune response influence infection by Mycobacterium tuberculosis. The proinflammatory cytokine interleukin (IL)-1β and its antagonist, IL-1Ra (IL-1 receptor agonist), are strongly induced by M. tuberculosis and are encoded by polymorphic genes. The induction of both IL-1Ra mRNA and secreted protein by M. tuberculosis in IL-1Ra allele A2–positive (IL-1Ra A2+) healthy subjects was 1.9-fold higher than in IL-1Ra A2 subjects. The M. tuberculosis–induced expression of mRNA for IL-1β was higher in subjects of the IL-1β (+3953) A1+ haplotype (P = 0.04). The molar ratio of IL-1Ra/IL-1β induced by M. tuberculosis was markedly higher in IL-1Ra A2+ individuals (P < 0.05), with minor overlap between the groups, reflecting linkage between the IL-1Ra A2 and IL-1β (+3953) A2 alleles. In M. tuberculosis–stimulated peripheral blood mononuclear cells, the addition of IL-4 increased IL-1Ra secretion, whereas interferon {gamma} increased and IL-10 decreased IL-1β production, indicative of a differential influence on the IL-1Ra/IL-1β ratio by cytokines. In a study of 114 healthy purified protein derivative–reactive subjects and 89 patients with tuberculosis, the frequency of allelic variants at two positions (–511 and +3953) in the IL-1β and IL-1Ra genes did not differ between the groups. However, the proinflammatory IL-1Ra A2/IL-1β (+3953) A1+ haplotype was unevenly distributed, being more common in patients with tuberculous pleurisy (92%) in comparison with healthy M. tuberculosis–sensitized control subjects or patients with other disease forms (57%, P = 0.028 and 56%, P = 0.024, respectively). Furthermore, the IL-1Ra A2+ haplotype was associated with a reduced Mantoux response to purified protein derivative of M. tuberculosis: 60% of tuberculin-nonreactive patients were of this type. Thus, the polymorphism at the IL-1 locus influences the cytokine response and may be a determinant of delayed-type hypersensitivity and disease expression in human tuberculosis.

Key Words: interleukin 1 receptor • tuberculosis • susceptibility, disease • hypersensitivity, delayed • granuloma


Address correspondence to Zahra Toossi, Division of Infectious Diseases, Case Western Reserve University, Biomedical Research Bldg., 10900 Euclid Ave., Cleveland, OH 44106-4984. Phone: 216-368-4844; Fax: 216-368-2034; E-mail: zxt2{at}po.cwru.edu

Dr. C.L. King (Case Western Reserve University) is thanked for providing DNA samples from Kenya. We are grateful to Drs. P.A. Zimmerman and J.J. Ellner for their critical review of the manuscript. We are grateful to the clinical, microbiological, and secretarial staff of Northwick Park Hospital, particularly Dr. R.A. Wall, Dr. M.G. Harries, Dr. M. Latif, and Miss Dina Shah. Manijeh Phillips and Beverly Hamilton are thanked for technical assistance. Dr. Carlos Moreno of King's College Hospital Medical School, London is thanked for encouraging this project in its early stages.

R.J. Wilkinson is a Wellcome Trust Fellow in Clinical Tropical Medicine. Additional support was provided by the National Institutes of Health (grant AI-18471), to P. Patel by an MSc studentship from Imperial College of Science, Technology and Medicine, and by the Medical Research Council of the United Kingdom.

Abbreviations used: DTH, delayed-type hypersensitivity; PPD, purified protein derivative; rt, room temperature.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS